19
192820.KO Cosmax Inc
- Market cap
- KRW 2.97T
- P/E
- 15.2x
- P/B
- 4.36x
- ROE
- 27.9%
- Dividend yield
- 0.88%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 192820.KO undervalued?
Graham number192820.KO trades 71.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cosmax Inc fundamental analysis
No fundamental analysis for Cosmax Inc yet.
Cosmax Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cosmax Inc
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, …
Full company profileCosmax Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cosmax Inc annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 757B | 884B | 1.26T | 1.33T | 1.38T | 1.59T | 1.60T | 1.78T | 2.17T | 2.40T | 2.95T |
| Gross Profit | 118B | 112B | 155B | 183B | 211B | 278B | 205B | 294B | 418B | 409B | 515B |
| Operating Income | 52.6B | 35.1B | 52.3B | 54.0B | 66.6B | 123B | 53.1B | 116B | 175B | 196B | 254B |
| EBITDA | - | 54.8B | 80.0B | 96.6B | 66.0B | 148B | 85.9B | 176B | 252B | 277B | 375B |
| Net Income | 34.8B | 18.9B | 32.6B | 31.8B | 21.4B | 74.4B | 20.8B | 57.1B | 85.8B | 123B | 181B |
| EPS | - | 1,844 | 3,191 | 3,113 | 2,091 | 6,561 | 1,838 | 5,036 | 7,562 | 10,847 | 15,912 |
| Balance Sheet | |||||||||||
| Total Assets | 666B | 934B | 1.06T | 1.20T | 1.19T | 1.41T | 1.40T | 1.56T | 1.93T | 2.13T | 2.67T |
| Total Liabilities | 459B | 706B | 820B | 888B | 917B | 947B | 952B | 1.20T | 1.42T | 1.51T | 1.96T |
| Shareholders' Equity | 211B | 218B | 265B | 343B | 343B | 561B | 581B | 363B | 473B | 558B | 647B |
| Cash & Short-term Investments | 68.3B | 39.0B | 35.2B | 76.6B | 103B | 99.8B | 169B | 257B | 256B | 192B | 337B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 23.5B | -6.62B | -54.6B | 74.6B | 41.5B | 100B | 103B | 231B | 73.0B | 86.7B | 126B |
| Capital Expenditure | 90.3B | 80.2B | 48.9B | 105B | 59.0B | 40.8B | 84.4B | 90.1B | 169B | 193B | 250B |
| Free Cash Flow | - | -173B | -106B | -31.6B | -18.9B | 57.9B | 18.2B | 141B | -95.6B | -106B | -124B |
| Ratios | |||||||||||
| ROE | 16.5% | 8.6% | 12.3% | 9.3% | 6.2% | 13.3% | 3.6% | 15.8% | 18.1% | 22.0% | 27.9% |
| ROA | 5.2% | 2.0% | 3.1% | 2.6% | 1.8% | 5.3% | 1.5% | 3.7% | 4.4% | 5.8% | 6.8% |
| Net Profit Margin | 4.6% | 2.1% | 2.6% | 2.4% | 1.5% | 4.7% | 1.3% | 3.2% | 4.0% | 5.1% | 6.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cosmax Inc dividends
- Dividend yield
- 0.88%
- Forward dividend
- 3,300.00 KRW
- Payout ratio
- 21.2%
- Ex-dividend date
- Mar 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 26.1B | 2,300 | 21.2% |
| 2024 | KRW 5.67B | 500 | 6.6% |
| 2023 | - | - | - |
| 2022 | KRW 6.26B | 552 | 30.0% |
| 2021 | - | - | - |
| 2020 | KRW 9.04B | 884 | 42.3% |
| 2019 | KRW 6.03B | 590 | 18.9% |
| 2018 | KRW 3.01B | 295 | 9.2% |
| 2017 | KRW 10.0B | 983 | 53.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1664:1635 on May 13, 2021.
Who owns Cosmax Inc
- Insiders 32.12%
- Institutions 43.42%
- Public & others 24.46%
- Shares outstanding 11.3M
- Free float 7.02M
Cosmax Inc company profile
- Company name
- Cosmax Inc
- Ticker
- 192820.KO
- ISIN
- KR7192820009
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 1,645
- Fiscal year end
- December
- Address
- 46, Jaekongdan 2-gil, Hwaseong-si, South Korea
- Phone
- 82 3 1359 0300
- Website
- cosmax.com
About Cosmax Inc
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.
Cosmax Inc management
4- Mr. Kyung-Soo LeeFounder & Chairman · born 1946
- Mr. Choi KyungVice Chairman & President · born 1952
- Mr. Jae-Cheon KimVice Chairman & CEO · born 1952
- Mr. Sung-Ki MoonVice Chairman & CEO of Cosmax BTI · born 1949